國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 852313      線上人數 : 1518
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版

    子類別

    報告 [0/1]
    專利 [0/11]
    期刊論文 [193/194]
    會議論文/會議摘要 [41/48]

    社群統計


    近3年內發表的文件:0(0.00%)
    含全文筆數:234(92.13%)

    文件下載次數統計
    下載大於0次:234(100.00%)
    下載大於100次:234(100.00%)
    檔案下載總次數:146303(2.73%)

    最後更新時間: 2024-11-28 10:27

    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目1-25 / 254. (共11頁)
    1 2 3 4 5 6 7 8 9 10 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2021-12-14 A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
    2021-11-16 Identification of prognostic biomarkers originating from the tumor stroma of betel quid-associated oral cancer tissues Frontiers in Oncology. 2021 Nov 16;11:Article number 769665.
    2021-04 Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors Oncologist. 2021 Apr;26(4):e567-e579.
    2021-03-11 c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation Theranostics. 2021 Mar 11;11(11):5232-5247.
    2021-03-04 Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy Theranostics. 2021 Mar 4;11(10):4672-4687.
    2021-01-12 Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells Scientific Reports. 2021 Jan 12;11:Article number 644.
    2020-08 The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells Toxicology and Applied Pharmacology. 2020 Aug;401:Article number 115080.
    2020-07-17 Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer[Erratum:Scientific Reports. 2019 Mar;9:Article number 3931.] Scientific Reports. 2020 Jul 17;10:Article number 12216.
    2020-06-28 Index of cancer-associated fibroblasts is superior to the epithelial–mesenchymal transition score in prognosis prediction Cancers. 2020 Jun 28;12(7):Article number 1718.
    2020-06 Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.
    2020-05-27 The tumor suppressor TGFBR3 blocks lymph node metastasis in head and neck cancer Cancers. 2020 May 27;12(6):Article number 1375.
    2020-04-02 MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer Journal of Biomedical Science. 2020 Apr 2;27:Article number 46.
    2020-03-31 Discoidin domain receptor-1 (DDR1) is involved in angiolymphatic invasion in oral cancer Cancers. 2020 Mar 31;12(4):Article number 841.
    2019-12 Lysosomal cysteine protease cathepsin S is involved in cancer cell motility by regulating store-operated Ca(2+) entry Biochimica et Biophysica Acta. Molecular Cell Research. 2019 Dec;1866(12):Article number 118517.
    2019-08-24 New insights into mechanisms of cisplatin resistance: From tumor cell to microenvironment International Journal of Molecular Sciences. 2019 Aug 24;20(17):Article number 4136.
    2019-07 Cathepsin S inhibition alleviates oxaliplatin-induced peripheral neuropathy through regulation of Ca2+homeostasis Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 2942.
    2019-06-01 Laminin gamma2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via intergrin alpha3-dependent uptake by lymphatic endothelial cells International Journal of Cancer. 2019 Jun 1;144(11):2795-2810.
    2019-06 Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial Head and Neck. 2019 Jun;41(6):1703-1712.
    2019-06 Validation of alcohol flushing questionnaire to identify ALDH2 status in a case-control study of head and neck cancer Alcoholism, Clinical and Experimental Research. 2019 Jun;43(6):1225-1233.
    2019-04 Oral hygiene and the overall survival of head and neck cancer patients Cancer Medicine. 2019 Apr;8(4):1854-1864.
    2019-03-20 TNF-alpha-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility PLoS ONE. 2019 Mar 20;14(3):Article number e0213463.
    2019-03 Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer Scientific Reports. 2019 Mar;9:Article number 3931.
    2019-02 The influence of prediagnosis alcohol consumption and the polymorphisms of ethanol metabolizing genes on the survival of head and neck cancer patients Cancer Epidemiology, Biomarkers and Prevention. 2019 Feb;28(2):248-257.
    2019-01-15 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase European Journal of Medicinal Chemistry. 2019 Jan 15;162:612-630.
    2018-12 Ubiquitin-conjugating enzyme E2 B regulates the ubiquitination of O(6)-methylguanine-DNA methyltransferase and BCNU sensitivity in human nasopharyngeal carcinoma cells Biochemical Pharmacology. 2018 Dec;158:327-338.

    顯示項目1-25 / 254. (共11頁)
    1 2 3 4 5 6 7 8 9 10 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋